0001161697-20-000604.txt : 20201228 0001161697-20-000604.hdr.sgml : 20201228 20201228164729 ACCESSION NUMBER: 0001161697-20-000604 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201222 FILED AS OF DATE: 20201228 DATE AS OF CHANGE: 20201228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: INGENITO GARY CENTRAL INDEX KEY: 0001279473 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 201418858 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 1500 CITY: CORAL GABLES STATE: FL ZIP: 33134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 1250 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 1250 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form4.xml FORM 4 FOR 12-22-2020 X0306 4 2020-12-22 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0001279473 INGENITO GARY 355 ALHAMBRA CIRCLE, SUITE 1250 CORAL GABLES FL 33134 0 1 0 0 Chief Medical Officer Common stock, par value $0.001 per share 2020-12-22 4 M 0 14666 A 14666 D Common stock, par value $0.001 per share 2020-12-22 4 S 0 3668 3.447 D 10998 D Restricted Stock Units 2020-12-22 4 M 0 14666 0 D Common Stock 14666 871334 D Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.and does not relate to any disagreements with the Company on any matter relating to the Company's operations, policies and practices. Dr. Ingenito remains an officer of the Company. Dr. Ingenito sold the shares on the open market to pay for taxes due on the vesting of the restricted stock units. Derivative securities vest in equal tranches, 1/3rd on December 2, 2020, 1/3rd on December 2, 2021 and 1/3rd on December 2, 2022. Shares of common stock will be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on December 22, 2020. /s/ Gary Ingenito 2020-12-23